COLTENE Holding AG (SWX:CLTN)
Switzerland · Delayed Price · Currency is CHF 48.65
-1.15 (-2.31%)
Apr 24, 2026, 5:30 PM CET
COLTENE Holding AG Market Cap
COLTENE Holding AG has a market cap or net worth of 297.57 million as of April 24, 2026. Its market cap has decreased by -18.63% in one year.
Market Cap
297.57M
Enterprise Value
323.83M
Revenue
240.05M
Ranking
n/a
PE Ratio
19.92
Stock Price
48.65
Market Cap Chart
Since June 23, 2006, COLTENE Holding AG's market cap has decreased from 435.24M to 297.57M, a decrease of -31.63%. That is a compound annual growth rate of -1.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 297.57M | -7.26% |
| Dec 30, 2025 | 320.88M | 4.48% |
| Dec 30, 2024 | 307.13M | -28.21% |
| Dec 29, 2023 | 427.85M | -6.04% |
| Dec 30, 2022 | 455.33M | -32.21% |
| Dec 30, 2021 | 671.65M | 30.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 259.45B |
| Novartis AG | 220.54B |
| Galderma Group AG | 37.70B |
| Lonza Group AG | 34.86B |
| Basilea Pharmaceutica AG | 662.52M |
| Newron Pharmaceuticals | 341.22M |
| DocMorris AG | 334.10M |
| IVF Hartmann Holding AG | 328.63M |